In Arizona, joining the ranks of Akron Biotechnology and others we’ve covered in the past, Lattice Biologics Ltd. is joining nearly 100 organizations in the Advanced Regenerative Manufacturing Institute (ARMI) an initiative comprised of public sector, government, nonprofits, and private sector aimed to advance next-generation technologies and biofabrication for cells, tissue and organs. Lattice Biologics is using human tissue based scaffolds that can support ingrowth of stem cells, preserve phenotypes of engrafted cells, and improve the time it takes for patients to heal. They use extracellular matrix from stem cells or from muscle or placenta tissue to create their biomaterial for cellular therapies and tissue engineering. Lattice Biologics is working with Arizona-based ASU Biodesign on their products.
Latest article
You better be-leaf it: Dawn Bio cultivates wood in a petri dish
In the Netherlands, a startup based at Wageningen University’s campus is pioneering technology to produce wood from cultured cells.
Dubbed Dawn Bio, the company has...
Algae-based snowboards from WNDR get nod from Time Magazine
In Utah, WNDR Alpine’s algae-based snowboards have been named to Time Magazine’s top 200 inventions list.
Unlike most snowboards, which are made out of petroleum-based...
Prince William’s Earthshot Prize names seaweed firm Coast 4C as a finalist
In Australia, a startup sustainably cultivating seaweed has been chosen as a finalist for Prince William’s 2024 Earthshot Prize.
Coast 4C works with farmers in...